Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Soileau who wrote (4)	6/16/1996 8:51:00 PM
From:	of 1501

This stock was recently covered by protrader, a newsletter out of zwiterland, via vancouver. I subscribe to it and its record is very good. The writers think the copmpany has fantaistic potential. He called it a buy at 80 cents can. and it went up to over 3 before settling down to its current 1.99. Recent developments include the following: 1. ceo in ny mid may to present his story to investment pro at equity's annual spring conference. It was according to protrader the most capivating story. 2.may 9: It announced a right offering to raise 3 mil. Part of the plan is for the investment house that did the rights offering to take stock to tse then nasdaq. Tse listing expected within weeks. 3. protrader sees royalties beginning in 2000 to company at 70 mil. He compares company to biochem pharma. 4. abbott very pleased with results from their initial testing of tb diagnostic kits. Licensing agrement expected to be completed far in advance of october target.Royalties then to come in a few million staring in 1997. Protrader says 3 mil sales translates to 3.85 - 4.62 using p/e of 25-30. 5. protrader recommends buying 50% up to 2.5 and 50% on any weakness.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next